Showing results (111-120 of 253) with videos related to
Sort By:
Pageof 26
Antiviral Therapy|February 13, 2014
Plasma lopinavir concentrations predict virological failure in a cohort of South African children initiating a protease-inhibitor-based regimenRetsilisitsoe R Moholisa, Michael Schomaker, Louise Kuhn, et al.The Journal of Antimicrobial Chemotherapy|August 19, 2023
Pharmacokinetics and optimized dosing of dispersible and non-dispersible levofloxacin formulations in young childrenLouvina E van der Laan, Anneke C Hesseling, H Simon Schaaf, et al.International Journal of Pharmaceutics|May 21, 2011
Absorption of the novel artemisinin derivatives artemisone and artemiside: potential application of Pheroid™ technologyJ Dewald Steyn, Lubbe Wiesner, Lissinda H du Plessis, et al.AIDS (London, England)|January 7, 2017
Determinants of virological outcome and adverse events in African children treated with paediatric nevirapine fixed-dose-combination tabletsAndrzej Bienczak, Paolo Denti, Adrian Cook, et al.AIDS (London, England)|October 27, 2016
Undisclosed HIV infection and antiretroviral therapy use in the Kenya AIDS indicator survey 2012: relevance to national targets for HIV diagnosis and treatmentAndrea A Kim, Irene Mukui, Peter W Young, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2016
Plasma Efavirenz Exposure, Sex, and Age Predict Virological Response in HIV-Infected African ChildrenAndrzej Bienczak, Paolo Denti, Adrian Cook, et al.Antimicrobial Agents and Chemotherapy|May 9, 2012
Population pharmacokinetics and pharmacodynamics of ofloxacin in South African patients with multidrug-resistant tuberculosisEmmanuel Chigutsa, Sandra Meredith, Lubbe Wiesner, et al.Medrxiv : the Preprint Server for Health Sciences|August 12, 2025
Pharmacokinetics of dexamethasone in tuberculosis meningitisJose M Calderin, Juan Eduardo Resendiz-Galvan, Noha Abdelgawad, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 26, 2024
Relationship Between Tenofovir Diphosphate Concentrations in Dried Blood Spots and Virological Outcomes After Initiating Tenofovir-Lamivudine-Dolutegravir as First-Line or Second-Line Antiretroviral TherapyJennifer Kate van Heerden, Graeme Meintjes, David Barr, et al.Antimicrobial Agents and Chemotherapy|December 9, 2015
Population Pharmacokinetics of Rifampin in Pregnant Women with Tuberculosis and HIV Coinfection in Soweto, South AfricaPaolo Denti, Neil Martinson, Silvia Cohn, et al.Pageof 26